Clinical trial
Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate…
NCT00302393 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00302393 |
|---|---|
| Title | Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults |
| Official title | A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy of Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | OROS methylphenidate hydrochloride, methylphenidate hydrochloride |
| Enrollment | 20 |
| Start date | Jun 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Mar 14, 2006 |
| Last update posted | Oct 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: